No products in the cart.
Efanesoctocog alfa is efficacious in treating severe hemophilia A
1. Efanesoctocog alfa was superior to prestudy factor VIII prophylaxis in preventing bleeding in patients with severe hemophilia A. 2. ...
Tag: hematology
Ferric derisomaltose may reduce heart failure-related hospitalizations
1. Risk of hospital admission was lower in the ferric derisomaltose group versus usual care. 2. Treatment-related adverse events were ...
Apixaban is associated with a lower risk of gastrointestinal bleeding than other direct oral anticoagulants
1. In this population-based cohort study, apixaban was associated with a lower risk of gastrointestinal bleeding (GIB) as compared to ...
Apixaban is superior to rivaroxaban in patients with atrial fibrillation and valvular heart disease
1. In comparison to rivaroxaban, apixaban was associated with a lower rate of bleeding events and embolic events amongst adults ...
Scoop thrombectomy safe and effective as a novel technique for treating thrombosed arteriovenous fistulas
1. Scoop thrombectomy is a safe and effective novel technique for treating thrombosed arteriovenous fistulas (AVFs) used for hemodialysis. Evidence ...
2 Minute Medicine Rewind October 17, 2022
Post-intensive care syndrome in out-of-hospital cardiac arrest patients: A prospective observational cohort study 1. Approximately half of patients with out-of-hospital ...
Rivaroxaban does not prevent cardiovascular events in rheumatic heart disease patients with atrial fibrillation
1. Rivaroxaban was not associated with a lower rate of cardiovascular events and death compared to vitamin K antagonist treatment ...
#VisualAbstract: Aspirin resulted in higher rate of venous thromboembolism following arthroplasty compared to enoxaparin
Click here to read this study in JAMA.
Mitapivat may improve anemia in adults with non-transfusion dependent α- and β-thalassemia
1. 80% of patients receiving mitapivat showed hemoglobin response at 12 weeks. 2. Markers of hemolysis, such as bilirubin and ...
Low-dose AAVS3 gene therapy is efficacious for treating patients with hemophilia B
1. Hemophilia B patients treated with the adeno-associated virus (AAV) gene therapy produced dose-dependent sustained factor IX levels. 2. All ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.